Avantium Faces Factory Delays and Downgraded Price Target

Amsterdam-based Avantium N.V., a company focused on renewable and circular polymer materials, is navigating a challenging period marked by delays in its flagship factory’s startup and a subsequent reduction in its stock price target. The company reported its 2025 full-year results on March 18, 2026, acknowledging a turbulent year but expressing optimism for the future.

Factory Startup Delayed to Mid-2026

The opening of Avantium’s modern factory in Delfzijl, Netherlands, has been pushed back to mid-2026, approximately five months later than initially projected. This delay stems from issues with titanium welding in the plant’s piping system, requiring an estimated 7 million euros in repairs [dekoersen.nl]. The plant is designed to produce furan dicarboxylic acid (FDCA), a biobased precursor for the bioplastic polyethylene furanoate (PEF) [biofuelsdigest.com].

Financial Impact and Price Target Revision

Degroof Petercam has lowered its price target for Avantium, initially reducing it from 14.00 euros to 12.00 euros, and subsequently to 10.00 euros while maintaining a ‘buy’ rating [beurs.nl]. This adjustment reflects the anticipated impact of the factory delay on Avantium’s revenue and cash flow. Analysts predict a 60 percent decrease in the company’s 2026 revenue estimates [dekoersen.nl].

Market Reaction and Investor Concerns

The news of the delay triggered a negative market reaction, with Avantium’s stock price falling 7.5 percent to 6.62 euros on the day of the announcement [dekoersen.nl]. Investors are concerned that the delayed revenue from FDCA and PEF sales will strain the company’s financial performance and potentially jeopardize existing offtake agreements.

2025 Full Year Results

Despite the challenges, Avantium CEO Tom van Aken stated that 2025 laid an “vital foundation for future commercial phase” [newsroom.avantium.com]. The full-year 2025 results were reported on March 18, 2026 [newsroom.avantium.com].

Looking Ahead

The market will closely monitor Avantium’s progress in resolving the factory issues and its ability to restore investor confidence. The timely completion of the Delfzijl plant and the successful execution of offtake agreements are crucial for the company’s future success in the rapidly evolving bioplastics market.